MLYS
Price
$13.53
Change
-$0.47 (-3.36%)
Updated
Apr 3 closing price
Capitalization
850.29M
45 days until earnings call
TRVI
Price
$6.22
Change
-$0.06 (-0.96%)
Updated
Apr 3 closing price
Capitalization
600.88M
34 days until earnings call
Ad is loading...

MLYS vs TRVI

Header iconMLYS vs TRVI Comparison
Open Charts MLYS vs TRVIBanner chart's image
Mineralys Therapeutics
Price$13.53
Change-$0.47 (-3.36%)
Volume$1.11M
Capitalization850.29M
Trevi Therapeutics
Price$6.22
Change-$0.06 (-0.96%)
Volume$1.06M
Capitalization600.88M
MLYS vs TRVI Comparison Chart
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. TRVI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and TRVI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MLYS: $13.53 vs. TRVI: $6.22)
Brand notoriety: MLYS and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 94% vs. TRVI: 43%
Market capitalization -- MLYS: $850.29M vs. TRVI: $600.88M
MLYS [@Biotechnology] is valued at $850.29M. TRVI’s [@Biotechnology] market capitalization is $600.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLYS and TRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while TRVI’s TA Score has 4 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 5 bearish.
  • TRVI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MLYS and TRVI are a good buy in the short-term.

Price Growth

MLYS (@Biotechnology) experienced а -9.80% price change this week, while TRVI (@Biotechnology) price change was -4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

MLYS is expected to report earnings on May 19, 2025.

TRVI is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($850M) has a higher market cap than TRVI($601M). TRVI YTD gains are higher at: 50.971 vs. MLYS (9.911). TRVI has higher annual earnings (EBITDA): -44.19M vs. MLYS (-192.36M). MLYS has more cash in the bank: 198M vs. TRVI (65.5M). MLYS (0) and TRVI (0) have equivalent revenues.
MLYSTRVIMLYS / TRVI
Capitalization850M601M141%
EBITDA-192.36M-44.19M435%
Gain YTD9.91150.97119%
P/E RatioN/AN/A-
Revenue00-
Total Cash198M65.5M302%
Total DebtN/A1.11M-
FUNDAMENTALS RATINGS
TRVI: Fundamental Ratings
TRVI
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSTRVI
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
88%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLFPX27.91N/A
N/A
Principal Large Cap S&P 500 Index R5
WLTTX10.69N/A
N/A
Wilshire International Equity Instl
CBBYX6.42N/A
N/A
AB Relative Value Advisor
RCSIX12.73N/A
N/A
RBC Small Cap Core I
CHDVX12.89-0.42
-3.16%
Cullen High Dividend Equity I

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-3.36%
PTGX - MLYS
47%
Loosely correlated
-3.53%
CKPT - MLYS
42%
Loosely correlated
N/A
ABOS - MLYS
34%
Loosely correlated
-8.52%
VCYT - MLYS
33%
Loosely correlated
-5.51%
CELC - MLYS
32%
Poorly correlated
-5.45%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-0.96%
PTGX - TRVI
41%
Loosely correlated
-3.53%
CKPT - TRVI
35%
Loosely correlated
N/A
MLYS - TRVI
30%
Poorly correlated
-3.36%
QURE - TRVI
30%
Poorly correlated
-8.19%
XENE - TRVI
29%
Poorly correlated
-2.38%
More